Bioequivalence study comparing two temazepam 20 mg tablet formulations after fasted administration; an open, randomized, single centre, single dose study with crossover design in healthy subjects
3137001
Phase 1 other active
Quick answer
Bioequivalence study comparing two temazepam 20 mg tablet formulations after fasted administration; an open, randomized, single centre, single dose study with crossover design in healthy subjects for short-term treatment of insomnia is a Phase 1 program (other) at Orion with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Orion
- Indication
- short-term treatment of insomnia
- Phase
- Phase 1
- Modality
- other
- Status
- active